101968-6
Circulating tumor cells [#/volume] in Plasma or Blood by Sequencing
Active
Part Description
LP150045-5 Sequencing
Sequencing is a method used to determine the sequence of individual genes, larger genetic regions (i.e. clusters of genes or operons), full chromosomes or entire genomes. Historically, most sequencing has been performed using the chain termination method developed by Frederick Sanger in 1977. PMID: 271968 Sequencing technologies have improved dramatically, making them cheaper, faster, and more accurate. Next-generation sequencing (NGS), also known as high-throughput sequencing, deep sequencing, and second-generation sequencing, is a type of technology that uses parallel sequencing of multiple small fragments of DNA to determine sequence. This "high-throughput" technology has increased the speed and amount of DNA sequenced at a significantly reduced cost. PMID: 18576944 Several NGS platforms (ie, sequencing instruments and associated reagents) have been developed. Third-generation sequencing is another methodology currently under development that uses parallel sequencing similar to NGS. In contrast to NGS, third-generation sequencing uses single DNA molecules rather than amplified DNA as a template. PMID: 20858600
Source: Regenstrief LOINC
LOINC Names Get Info
- Fully-Specified Name
- Circulating tumor cells:
NCnc: Pt: Plas/Bld: Qn: Sequencing - Long Common Name
- Circulating tumor cells [#/volume] in Plasma or Blood by Sequencing
- Short Name
- Circ Tumor cells # PlasBld Seq
- Display Name
- Circulating tumor cells Sequencing (P/Bld) [#/Vol]
- Consumer Name Alpha Get Info
- Circulating tumor cells, Blood
Part Model Get Info
- Component
- Circulating tumor cells
LP135291-5
- Analyte
- Circulating tumor cells
LP135291-5
- Component Numerator
- Circulating tumor cells
LP135291-5
- Component Numerator Core
- Circulating tumor cells
LP135291-5
- Component Numerator Core Suffix
- NULL
- Component Denominator
- NULL
- Component Denominator Core
- NULL
- Component Denominator Core Suffix
- NULL
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- NCnc
LP6836-3
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- Plas/Bld
LP185760-8
- System Core
- Plas/Bld
LP185760-8
- Super System
- NULL
- Scale
- Qn
LP7753-9
- Method
- Sequencing
LP150045-5
Basic Attributes
- Class
- CHEM
- Type
- Laboratory
- First Released
- Version 2.75
- Last Updated
- Version 2.75 (ADD)
- Order vs. Observation
- Both
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | Cirkulující nádorové buňky: |
| el-GR | Greek (Greece) | Κυκλοφορούντα καρκινικά κύτταρα: Synonyms: CHEM NCnc Pt Qn Αίμα Αλληλούχιση Κυκλοφορούντα καρκινικά κύτταρα Κύτταρα Πλάσμα Πλάσμα/Αίμα |
| es-ES | Spanish (Spain) | Células tumorales circulantes: Synonyms: Cuantitativo |
| fr-FR | French (France) | Cellules tumorales circulantes: |
| it-IT | Italian (Italy) | Cellule tumorali circolanti: Synonyms: Chimica Concentrazione Numerica Plasma Plasma o Sangue Punto nel tempo (episodio) Sangue Tumore circolante |
| nl-NL | Dutch (Netherlands) | circulerende tumorcellen: Synonyms: CTC |
| zh-CN | Chinese (China) | 循环肿瘤细胞: Synonyms: 化学; |
Example Units
| Unit | Source |
|---|---|
| mol/mL | Example UCUM Units |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://